Merck & Co., Inc. (NYSE:MRK) Price Target Cut to $132.00
Merck & Co., Inc. (NYSE:MRK – Free Report) had its price objective cut by Truist Financial from $143.00 to $132.00 in a research report report published on Wednesday, Benzinga reports. They currently have a buy rating on the stock. MRK has been the subject of several other reports. Bank of America decreased their price target […]
13 Oct 10:02 · The Markets Daily